Vimarsana
Biggest News Aggregation in the World

Page 8 - Nyse Path News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nyse Path. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nyse Path Today - Breaking & Trending Today

Citizens Financial Group Inc. RI Takes Position in UiPath Inc. (NYSE:PATH) - Vimarsana News

Citizens Financial Group Inc. RI Takes Position in UiPath Inc. (NYSE:PATH)

Citizens Financial Group Inc. RI bought a new position in UiPath Inc. (NYSE:PATH – Free Report) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 21,680 shares of the healthcare company’s stock, valued at approximately $359,000. Other large investors have also […]

Source: wkrb13.com
Oppenheimer & Co. Inc. Boosts Stake in UiPath Inc. (NYSE:PATH) - Vimarsana News

Oppenheimer & Co. Inc. Boosts Stake in UiPath Inc. (NYSE:PATH)

Oppenheimer & Co. Inc. increased its position in UiPath Inc. (NYSE:PATH – Free Report) by 14.2% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 202,469 shares of the healthcare company’s stock after buying an additional 25,147 shares during the period. Oppenheimer […]

iTWire - UiPath Clipboard AI Named One of TIME's Best Inventions of 2023 - Vimarsana News

iTWire - UiPath Clipboard AI Named One of TIME's Best Inventions of 2023

COMPANY NEWS:  UiPath (NYSE: PATH), a leading enterprise automation software company, today announced UiPath Clipboard AI has been selected as on...

Source: itwire.com
UiPath Inc. (NYSE:PATH) Receives Consensus Recommendation of "Hold" from Analysts - Vimarsana News

UiPath Inc. (NYSE:PATH) Receives Consensus Recommendation of "Hold" from Analysts

Shares of UiPath Inc. (NYSE:PATH – Get Free Report) have been assigned an average recommendation of “Hold” from the fifteen research firms that are presently covering the firm, MarketBeat Ratings reports. Nine equities research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average […]

UiPath's (PATH) "Buy" Rating Reiterated at Needham & Company LLC - Vimarsana News

UiPath's (PATH) "Buy" Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated their buy rating on shares of UiPath (NYSE:PATH – Free Report) in a research report report published on Wednesday, Benzinga reports. They currently have a $20.00 price target on the healthcare company’s stock. Several other equities analysts have also commented on the stock. Barclays upped their price objective on shares […]